editor-in chief carlo brugnara boston children s hospital

Submit Demands Online

Children's Hospital Medical Center Michael P Walsh S J ' Boston College High School Vincent C Ziegler L L D '75 (Hon ) Chairman of the Executive Committee and Director The Gillette Company Inc James P O'Neill '42' Senior Vice President Xerox L L Editor-in-Chief Bernard Perbal EDASE Marseille France President of the International CCN Society Managing Editor Andrew Leask University of Saskatchewan Saskatoon Canada Section Editors Pathology and Translational Research Andrew Leask University of Saskatchewan Saskatoon Canada

Genes Cancer

Editor-in-Chief E Premkumar Reddy PhD Mount Sinai School of Medicine New York USA Assistant Editor Stacey J Baker PhD Mount Sinai School of Medicine New York USA Editorial Board Stuart son Mount Sinai School of Medicine USA Dario Altieri The Wistar Institute USA

The revolution that's about to transform blood testing Forget labs and microscopes: 3 Israeli startups aim to disrupt the field of blood testing using advanced technologies that give on-the-spot results The way blood-cell counts and diagnostic blood tests are done

2003/3/1Dr Carlo Brugnara MD is Professor of Pathology at Harvard Medical School and Director of the Hematology Laboratory at Children's Hospital Boston He received his MD from the University of Verona Italy in 1979 In 1982 he joined the laboratory of Dr Daniel

Dr Carlo Brugnara: Editor in Chief American Journal of Hematology Dr Michael Picard: Editor in Chief Journal of the American Society of Echocardiography Dr Jeff Drazen: Professor of Medicine Harvard Dr Monica Bertagnolli: Chair Board of Directors American

Editor-in-Chief Bernard Perbal EDASE Marseille France President of the International CCN Society Managing Editor Andrew Leask University of Saskatchewan Saskatoon Canada Section Editors Pathology and Translational Research Andrew Leask University of Saskatchewan Saskatoon Canada

JACC: CardioOncology Editorial Board

Find out more about the editorial board for JACC: CardioOncology Author Stats ℹ Author Stats: Publishing your article with us has many benefits such as having access to a personal dashboard: citation and usage data on your publications in one place

Editor-in-Chief Francesc Palau Hospital Sant Joan de Du Barcelona and CIBERER Spain Managing Editor ia Corrochano Centre for Biomedical Network Research on Rare Diseases Spain Section Editors Adult oncology Payal Khincha NIH USA Uberta Verga Policlinico of Milan Italy Clinical genetics and genomics Nan Wu Baylor College of Medicine USA

Editor-in-Chief Maurizio Gallieni University of Milano Milan Italy ASDIN Editor Aris Q Urbanes Wayne State University Detroit MI USA JSDA Editor Hideki Kawanishi Tsuchiya General Hospital Hiroshima Japan VAS Editor Jan Tordoir Maastricht University Medical

Editor-in-Chief Francesc Palau Hospital Sant Joan de Du Barcelona and CIBERER Spain Managing Editor ia Corrochano Centre for Biomedical Network Research on Rare Diseases Spain Section Editors Adult oncology Payal Khincha NIH USA Uberta Verga Policlinico of Milan Italy Clinical genetics and genomics Nan Wu Baylor College of Medicine USA

Associate Editors Clinical diagnostics and imaging Andre Aihara University Sao Paulo Brazil Domenico Albano IRCCS Istituto Ortopedico Galeazzi Italy Alex Breen AECC University College UK Ke-Vin Chang National Taiwan University Taiwan Avneesh Chhabra University of Texas Southwestern USA Ji-Ying Chen General Hospital of People's Liberation Army China Shadi Ebrahimian Massachusetts

Find out more about the editorial board for JACC: CardioOncology Author Stats ℹ Author Stats: Publishing your article with us has many benefits such as having access to a personal dashboard: citation and usage data on your publications in one place

Editorial Testing Hearing in Hostile Environments A s we contemplate the possibility of mandated mass screening of the hear-ing of newborn babies it is perhaps relevant to consider that for the fore-seeable future such screening is likely to be carried out in hostile

In 1992 he joined the Department of Laboratory Medicine at Boston Children's Hospital as Director of the Hematology Laboratory Dr Brugnara is a fellow of the American Society of Clinical Investigation the Association of American Physicians and the Academy of Clinical Laboratory Physicians and Scientists

New editorial board member

2003/3/1Dr Carlo Brugnara MD is Professor of Pathology at Harvard Medical School and Director of the Hematology Laboratory at Children's Hospital Boston He received his MD from the University of Verona Italy in 1979 In 1982 he joined the laboratory of Dr Daniel

Senicapoc was tested in the early 2000s for sickle cell anemia which had only one approved therapy at the time (hydroxyurea developed at Boston Children's Hospital more than 30 years ago) Then called ICA-17043 senicapoc showed a good safety profile in a Phase 2 clinical trial

Children's Hospital Medical Center Michael P Walsh S J ' Boston College High School Vincent C Ziegler L L D '75 (Hon ) Chairman of the Executive Committee and Director The Gillette Company Inc James P O'Neill '42' Senior Vice President Xerox L L

Carlo Brugnara Affiliations and Expertise Children's Hospital Boston Request Quote Tax Exemption We cannot process tax exempt orders online If you wish to place a tax exempt order please contact us Solutions Solutions Scopus ScienceDirect

2003/3/1Dr Carlo Brugnara MD is Professor of Pathology at Harvard Medical School and Director of the Hematology Laboratory at Children's Hospital Boston He received his MD from the University of Verona Italy in 1979 In 1982 he joined the laboratory of Dr Daniel